[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Pages 40050-40051]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15795]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-21-0800; Docket No. CDC-2021-0072]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Focus Group Testing to 
Effectively Plan and Tailor Cancer Prevention and Control Communication 
Campaigns. CDC is requesting a Revision to this Generic Clearance to 
include an additional cancer-related communications campaign, expand 
the modes of data collection to include online focus groups and in-
depth interviews (in-person, phone, and online), and to focus on 
respondents from the general public.

DATES: CDC must receive written comments on or before September 24, 
2021.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0072 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Focus Group Testing to Effectively Plan and Tailor Cancer 
Prevention and Control Communications Campaigns--(OMB Control No. 0920-
0800, Exp. 10/31/2021)--Revision--National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    The mission of the CDC's Division of Cancer Prevention and Control 
(DCPC) is to reduce the burden of cancer in the United States through 
cancer prevention, reduction of risk, early detection, and improved 
quality of life for cancer survivors. Toward this end, the DCPC 
supports the scientific development and implementation of various 
health communication campaigns with an emphasis on specific cancer 
burdens.
    This process requires testing of messages, concepts, and materials 
prior to their final development and dissemination, as described in the 
second step of the health communication process. The health 
communication process is a scientific model developed by the U.S. 
Department of Health and Human Services' National Cancer Institute to 
guide sound campaign development. The communication literature supports 
various data collection methods to conduct credible formative, concept, 
message, and materials testing. This process ensures that the public 
clearly understands cancer-specific information and concepts, are 
motivated to take the desired action, and do not react negatively to 
the messages. CDC is currently approved to collect information needed 
to plan and tailor cancer communication campaigns (OMB Control No. 
0920-0800, Exp. 10/31/2021), and seeks OMB approval to revise the 
existing generic clearance to include another cancer-related 
communications campaign, expand the modes of data collection to include 
online focus groups and in-depth interviews (in-person, phone, and 
online), and to focus on respondents from the general public.
    Information collection will involve discussions to assess numerous 
qualitative dimensions of cancer prevention and control messages 
including, but not limited to, cancer knowledge, attitudes, beliefs, 
behavioral intentions, information needs and sources, and compliance 
with cancer screening as recommended by the United States Preventive 
Services Task Force. Insights gained from these discussions will assist 
in the development and/or refinement of future campaign messages and 
materials. Communication campaigns and messages will vary according to 
the type of cancer and the qualitative dimensions of the message 
described above. A separate information collection

[[Page 40051]]

request will be submitted to OMB for approval of each discussion 
activity. The request will describe the purpose of the activity and 
include the customized information collection instruments.
    OMB approval is requested for three years. There is no change in 
burden hours or respondents. Participation is voluntary and there are 
no costs to respondents except their time. CDC requests approval for an 
estimated 1,680 annual burden hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
General Public................  Screening Form..            1600               1            3/60              80
General Public................  Discussion Guide             800               1               2           1,600
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           1,680
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-15795 Filed 7-23-21; 8:45 am]
BILLING CODE 4163-18-P